[ExI] Problem with Pattents

Rafal Smigrodzki rafal.smigrodzki at gmail.com
Tue Mar 4 01:24:52 UTC 2008


On Mon, Feb 25, 2008 at 11:16 PM, Tom Tobin <korpios at korpios.com> wrote:

> On 2/25/08, Rafal Smigrodzki <rafal.smigrodzki at gmail.com> wrote:
> > On Mon, Feb 25, 2008 at 3:44 PM, Tom Tobin <korpios at korpios.com> wrote:
> >
> >  >  I think we're looking at the situation the wrong way.  Instead of
> "How
> >  >  can pharma companies recoup their R&D costs?", I'd like to ask "Is
> >  >  there a better way to enrich the public good regarding medicine?"
> >  >  Between the questionable efficacy of many medical products and a
> >  >  laborious FDA approval process, I don't think the current system is
> a
> >  >  net gain; I'd rather see slower (and, hopefully, steadier) progress
> >  >  (with a combination of public financing, cheap generics, and looser
> >  >  regulations during a "prototype" testing period).  I'd also like to
> >  >  see *far* more emphasis placed on prevention rather than treatment;
> >  >  prevention is both cheaper *and* more effective.  A healthy diet and
> >  >  exercise regimen alone is worth more than the fruit of decades of
> >  >  research into new drugs.
> >
> >
> > ### Yeah? How does that solve the problem of e.g. glioblastoma
> >  multiforme? Healthy eating? Prevention??? lol
>
> Prevention would help knock down a whole host of easy targets that
> claim plenty of lives; when heart disease kills 268 people out of
> every 100,000 per year, tossing up an example with a 2 per 100,000
> incident rate makes me scratch my head.


### What does heart disease  prevention have to do with IP?

Rafal
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20080303/edd7a7b2/attachment.html>


More information about the extropy-chat mailing list